In addition to established factors, such as alanine aminotransferase (ALT) and metabolic syndrome, previously overlooked aspects, such as inflammation, gut microbiota, and oxidative stress, have gained significant attention as notable contributors to the pathogenesis of MASLD/NAFLD. The gene discussed is GPT; the disease is metabolic syndrome.